Gene/Event |
Cancer Type |
Patient |
Variant |
Mutation Level |
TACC2 |
Breast Cancer | p143_p5 |
Chr10:123844826:G>A |
Private mutation |
TACC2 |
Colorectal Cancer | p034_MSU2 |
Chr10:123843197:C>T |
Trunk mutation |
TACC2 |
Colorectal Cancer | p034_MSU2 |
Chr10:123842830:A>T |
Private mutation |
TACC2 |
Colorectal Cancer | p034_MSU3 |
Chr10:123970379:A>AC |
Private mutation |
TACC2 |
Colorectal Cancer | p034_MSU4 |
Chr10:123847099:C>A |
Trunk mutation |
TACC2 |
Colorectal Cancer | p040_case6 |
Chr10:123846278:C>T |
Trunk mutation |
TACC2 |
Colorectal Cancer | p104_UC03 |
p.K2382K |
Branch mutation |
TACC2 |
Esophageal Squamous Cell Carcinoma | p124_ESCC012 |
p.I1668M |
Branch mutation |
TACC2 |
Esophageal Squamous Cell Carcinoma | p128_P06 |
Chr10:123843435:G>C |
Private mutation |
TACC2 |
Esophageal Squamous Cell Carcinoma | p128_P12 |
Chr10:123844324:C>T |
Private mutation |
TACC2 |
Esophageal Squamous Cell Carcinoma | p128_SP07 |
Chr10:123843848:C>G |
Trunk mutation |
TACC2 |
Esophageal Squamous Cell Carcinoma | p128_SP13 |
Chr10:123987417:G>A |
Private mutation |
TACC2 |
Esophageal Squamous Cell Carcinoma | p139_EC1113 |
p.R104Q |
Branch mutation |
TACC2 |
Gastric Adenocarcinoma | p011_MSI-H1 |
p.W821C |
Private mutation |
TACC2 |
Gastric Carcinoma | p106_GC07 |
p.P1595P |
Private mutation |
TACC2 |
Gastric Carcinoma | p106_GC09 |
p.P1500P |
Private mutation |
TACC2 |
Gastric Carcinoma | p106_GC09 |
p.C310C |
Private mutation |
TACC2 |
Gastric Carcinoma | p106_GC09 |
p.S1050P |
Private mutation |
TACC2 |
Glioblastoma | p113_case07 |
p.S1679N |
Private mutation |
TACC2 |
Glioblastoma | p113_case07 |
p.E1995K |
Private mutation |
TACC2 |
Glioblastoma | p113_case15 |
p.G752V |
Trunk mutation |
TACC2 |
Glioma | p168_P18 |
p.D590N |
Private mutation |
TACC2 |
Intrahepatic Cholangiocarcinoma | p080_ICC880 |
p.D675H |
Private mutation |
TACC2 |
Lung Adenocarcinoma | p017_4990 |
Chr10:123809859:G>A |
Branch mutation |
TACC2 |
Lung Adenocarcinoma | p017_317ss |
Chr10:123954681:G>T |
Trunk mutation |
TACC2 |
Melanoma | p043_C |
p.P2298L |
Private mutation |
TACC2 |
Melanoma | p043_F |
p.S1832L |
Trunk mutation |
TACC2 |
Melanoma | p043_H |
p.E1988* |
Private mutation |
TACC2 |
Melanoma | p135_p01 |
Chr10:123970197:C>T |
Trunk mutation |
TACC2 |
Melanoma | p135_p10 |
Chr10:123845682:C>T |
Trunk mutation |
TACC2 |
Melanoma | p135_p11 |
Chr10:123845990:C>T |
Trunk mutation |
TACC2 |
Melanoma | p135_p16 |
Chr10:123847433:G>A |
Trunk mutation |
TACC2 |
Melanoma | p135_p26 |
Chr10:123844338:C>T |
Trunk mutation |
TACC2 |
Melanoma | p135_p27 |
Chr10:124008594:G>A |
Trunk mutation |
TACC2 |
Prostate Cancer | p164_P1 |
p.V275A |
Branch mutation |
TACC2 |
Prostate Cancer | p164_P1 |
p.A288V |
Branch mutation |
TACC2 |
Prostate Cancer | p164_P1 |
p.L339H |
Branch mutation |
TACC2 |
Prostate Cancer | p164_P1 |
p.G298D |
Private mutation |
TACC2 |
Prostate Cancer | p164_P2 |
p.V275A |
Branch mutation |
TACC2 |
Prostate Cancer | p164_P2 |
p.R133H |
Private mutation |
TACC2 |
Prostate Cancer | p164_P2 |
p.L830F |
Private mutation |
TACC2 |
Renal Cell Carcinoma | p073_RCC4 |
Chr10:123987270:T>C |
Private mutation |
TACC2 |
Urothelial Carcinoma | p031_WCM117 |
p.A1881S |
Private mutation |
TACC2 |
Urothelial Carcinoma | p142_p07 |
- |
Private mutation |
TACC2 |
Urothelial Carcinoma | p142_p18 |
- |
Private mutation |